Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis
Sponsor: FDA Office of Orphan Products Development
A NA clinical study on Tuberculosis, Pulmonary, this trial is completed. The trial is conducted by FDA Office of Orphan Products Development and has accumulated 5 data snapshots since 1994. Infectious disease trials contribute critical data for public health response and treatment development.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Nov 1994
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- FDA Office of Orphan Products Development
- University of Illinois at Chicago
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.